These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16817763)

  • 1. Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model.
    Liu Y; Hu R; Zhang S; Zhang F; Li Z; Wei X; Chen L
    Viral Immunol; 2006; 19(2):202-9. PubMed ID: 16817763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q; Moraes MP; Grubman MJ
    Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model.
    Ren XG; Xue F; Zhu YM; Tong GZ; Wang YH; Feng JK; Shi HF; Gao YR
    Biotechnol Lett; 2009 Aug; 31(8):1159-65. PubMed ID: 19343503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
    Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ
    Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses.
    Mahdy SE; Liu S; Su L; Zhang X; Chen H; Pei X; Wang C
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1919-1929. PubMed ID: 30627793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.
    Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement of mouse immune response by recombinant adenovirus co-expressing VP1-2A of foot-and-mouth disease virus and porcine IFN-α].
    Su C; Duan X; Cao R; Zheng J; Chen P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1129-32. PubMed ID: 25374073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus.
    Zhou JX; Xue JD; Yu T; Zhang JB; Liu Y; Jiang N; Li YL; Hu RL
    Vet Res Commun; 2010 Apr; 34(4):371-80. PubMed ID: 20432066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.